DMTK - DermTech study finds melanoma test effective for all skin types
2024-01-18 15:04:11 ET
More on DermTech
- DermTech, Inc. (DMTK) Q3 2023 Earnings Call Transcript
- DermTech stock rallies 18% on positive study for melanoma test
- DermTech Q3 2023 Earnings Preview
- Seeking Alpha’s Quant Rating on DermTech
- Historical earnings data for DermTech
For further details see:
DermTech study finds melanoma test effective for all skin types